Recombinant Mouse IFN gamma(Cat. No.:CM40) novoprotein
$65.00
In stock
SKU
CM40
10μg: $65
50μg: $150
500μg: $1120
1mg: $1600
Description
Recombinant Mouse Interferon Gamma is produced by our Mammalian expression system and the target gene encoding His23-Cys155 is expressed.
Product Details
| Item | Details |
| Known As | Ifng; Interferon gamma; IFN-gamma |
| Mol Mass | 15.5 KDa |
| APMol Mass | 12-20 KDa, reducing conditions |
| Formulation Description | Lyophilized from a 0.2 μm filtered solution of PBS, pH 7.4. |
| Endotoxin | < 1 EU/µg as determined by LAL test. |
| Reconstitution | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
| Storage | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
| Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature listed below. |
Background
Mouse Ifng is a secreted protein which belongs to the type I I (or gamma) interferon family. IFNG is produced by lymphocytes and activated by specific antigens or mitogens. In addition to having antiviral activity, IFNG also has important immunoregulatory functions. It is a potent activator of macrophages and has antiproliferative effects on transformed cells. It can potentiate the antiviral and antitumor effects of the type I interferons. Genetic variation in IFNG is associated with the risk of aplastic anemia (AA) which is a rare disease in which the reduction of the circulating blood cells results from damage to the stem cell pool in bone marrow. In most patients, the stem cell lesion is caused by an autoimmune attack. T-lymphocytes, activated by an endogenous or exogenous, and most often unknown antigenic stimulus, secrete cytokines, including IFN-gamma, which would in turn be able to suppress hematopoiesis.
title: Rhodanine-Inspired Development of Dual-Action Mycobacterium tuberculosis Protein Tyrosine Phosphatase B Inhibitors
authors: Haofan Shao, Xiaoyu Wu, Shihao Cheng, Bin Wang, Xi Chen, Yixuan Zheng, Zhenfa Yang, Jiang Li, Fei Ye, Yu Lu, Haihong Huang, Zhenhuang Ge, Dongfeng Zhang
date: 2026/05/06
journal: JOURNAL OF MEDICINAL CHEMISTRY
title: Engineering Oncolytic Virus-Armed Macrophages for Enhanced Cancer Immunotherapy
authors: Jilong Wang, Ning Lu, Zhuo Yan, Luyi Ye, Luyao Bai, Shanshan Yuan, Yuting Zhu, Yiru Xiong, Yongheng Bai, Yaping Chen, Junjie Deng
date: 2026/04/20
journal: Advanced Science
title: Hypoxia nanoalleviator with dual disruption of iron and redox metabolism for efficient ferroptosis-mediated cancer immunotherapy
authors: Yin Weimin, Li Yang, Chen Shiyu, Zhi Hui, Chang Jiao, Chen Nana, Yang Zichen, Xiao Yaping, Li Yan, Li Yongyong, Ma Bin, Dong Haiqing
date: 2026/04/09
journal: Advanced Composites and Hybrid Materials
title: Macrophage phenotype modulation via 2-hydroxypropyltrimethyl ammonium chloride chitosan: a novel strategy for managing allergic rhinitis
authors: Yi Peng, Cuida Meng, Yu Liu, Kejia Li, Meng Zhu, Xiaoyan Ju, Ye Tian, Dongdong Zhu, Zhongwei Niu
date: 2026/04/07
journal: Biomaterials Science
title: Engineered Self-Activatable Polymeric Nanozymes Precisely Eradicate Tumor-Associated Intramacrophage Bacteria to Potentiate Immunotherapy Based on Cluster of Differentiation 47 Blockade
authors: Yunjian Yu, Jialu Bai, Juntao Fan, Zhuoyan Cui, Yong Zhou, Jinhao Chen, Youtao Xin, Meihui Su, Mahmoud Elsabahy, Hui Gao
date: 2026/2/19
journal: ACS Nano
title: Luminal hormone-responsive cells tune the regenerative remodeling of mammary glands in large mammals
authors: Li Yongtao, Zhang Liping, Luo Tao, Zhang Wenying, Wang Teng, Liu Fanming, Lin Shengda, Luo Jun, Liu Jianxin, Peng Jinrong, Wang Chaochen, Wang Wei, Shi Hengbo
date: 2025/12/30
journal: Cell Discovery
title: In situ DC-primed vaccine combined with CD137 agonist elicits long-lasting antitumor immunity through cDC1-mediated tumor antigen-specific CD8+ T cell responses
authors: Mengjiao Wang, Li Qiu, Cheng Tang, Danqing Huang, Qiaocong Zheng, Zunyi Li, Zhenhui Zhang, Shupei Wei, Lanfang Chen, Hongxin Huang, Jun Liu, Junfeng Zhou, Tao Lu, Guanxin Liu, Yingjie Nie, Qibin Leng, Tao Chen
date: 2025/12/12
journal: Journal for ImmunoTherapy of Cancer
title: Delayed administration of Jiuwei Qianghuo Decoction combined with Zhuye Shigao Decoction mitigates the severity of influenza A virus infection by inhibiting cell death and alleviating the subsequent cytokine storm response
authors: Shaoyan Zhang, Xianwei Wu, Xing Huang, Lei Qiu, Ya Feng, Jiajun Chen, Chenglong Shao, Ben Su, Zhuannan Hu, Cui Li, Peiyong Zheng, Zhenhui Lu
date: 2025/09/07
journal: JOURNAL OF ETHNOPHARMACOLOGY
title: GD2-mediated impairment of macrophage phagocytosis drives pulmonary metastasis in osteosarcoma
authors: Yunfei He, Peng Yang, Peng Ding, Zeng Zhang, Jichuan Wu, Chunjie Wang, Guanghui Hou, Jun Ge, Quan Zhou, Zhuorun Song, Huilin Yang, Tao Liu, Shunyi Lu
date: 2025/06/20
journal: Theranostics
title: STAT1 mediates the pro-inflammatory role of GBP5 in colitis
authors: Li Yichen, Wang Wenxia, Zhu Ruixin, Zhu Xinyue, Sun Mingwei, Huang Yanlan, Chen Wanning, Gao Sheng, Jiao Na, Lin Xutao, Ke Jia, Xu Tao, Hou Linlin, Lan Ping, Zhu Lixin
date: 2025/03/07
journal: Communications Biology
title: Pyroptosis-Inducing Self-Adaptor to Potentiate Immune Checkpoint Blockade Therapy for Breast Cancer by Reeducating the Treatment-Recruited Macrophages
authors: Zi-Wen Qiu, Ying-Tao Zhong, Zhen-Ming Lu, Ke-Yan Zhang, Zhuo-Feng Li, Jun-Mei Nie, Hong Cheng
date: 2024/12/31
journal: ADVANCED FUNCTIONAL MATERIALS
title: Puerarin inhibits macrophage M1 polarization by combining STAT1 to reduce myocardial damage in EAM model mice
authors: Xihui Jia, Ling Li, Tiantian Wang, Xiaoran Ma, Chenglin Li, Meng Liu, Huimin Tong, Shuang Wang
date: 2024/09/14
journal: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
title: Nano-mechanical Immunoengineering: Nanoparticle Elasticity Reprograms Tumor-Associated Macrophages via Piezo1
authors: Zichen Yang, Yuge Zhao, Xiaoyou Zhang, Li Huang, Kun Wang, Jiuyuan Sun, Nana Chen, Weimin Yin, Shiyu Chen, Hui Zhi, Liangyi Xue, Lulu An, Rongjie Li, Haiqing Dong, Jinfu Xu, Yan Li, Yongyong Li
date: 2024/07/30
journal: ACS Nano
title: A polymeric nanoplatform enhances the cGAS-STING pathway in macrophages to potentiate phagocytosis for cancer immunotherapy
authors: Yongjuan Li, Jinmeng Yi, Rong Ma, Yayun Wang, Xiaohan Lou, Ya Dong, Yongjian Cao, Xinyan Li, Ming Wang, Xiaowei Dang, Rui Li, Ningjing Lei, Haiwei Song, Zhihai Qin, Weijing Yang
date: 2024/07/25
journal: JOURNAL OF CONTROLLED RELEASE
title: Rabeprazole mitigates obesity-induced chronic inflammation and insulin resistance associated with increased M2-type macrophage polarization
authors: Yunfang Li, Jiayue Hao, Xianghui Kong, Weiyi Yuan, Yingying Shen, Zhaoyuan Hui, Xinliang Lu
date: 2024/03/31
journal: BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
title: Local thiamet-G delivery by a thermosensitive hydrogel confers ischemic cardiac repair via myeloid M2-like activation in a STAT6 O-GlcNAcylation-dependent manner
authors: Wenjing Zhou, Qingsong Tang, Shengnan Wang, Liang Ding, Ming Chen, Hongman Liu, Yong Wu, Xiwen Xiong, Zhenya Shen, Weiqian Chen
date: 2024/03/18
journal: INTERNATIONAL IMMUNOPHARMACOLOGY
title: GSDMD and GSDME synergy in the transition of acute kidney injury to chronic kidney disease
authors: Chen Zhengyue, Chen Caiming, Lai Kunmei, Wu Chengkun, Wu Fan, Chen Zhimin, Ye Keng, Xie Jingzhi, Ma Huabin, Chen Hong, Wang Yujia, Xu Yanfang
date: 2024/01/19
journal: NEPHROLOGY DIALYSIS TRANSPLANTATION
title: Enhancing Liver Delivery of Gold Nanoclusters via Human Serum Albumin Encapsulation for Autoimmune Hepatitis Alleviation
authors: Cong Meng, Yu Liu, Yuping Ming, Cao Lu, Yanggege Li, Yulu Zhang, Dongdong Su, Xueyun Gao, Qing Yuan
date: 2024/01/14
journal: Pharmaceutics
title: Multifunctional DNA-Based Hydrogel Promotes Diabetic Alveolar Bone Defect Reconstruction
authors: Ge Peng, Wei Li, Linrui Peng, Ruoqing Li, Zhenghao Wang, Ye Zhou, Liping Gou, Xinyue Zhu, Qingxing Xie, Xinyi Zhang, Sumin Shen, Lei Wu, Liqiang Hu, Chengshi Wang, Xiaofeng Zheng, Nanwei Tong
date: 2023-11-02
journal: Small
title: Cryoablation inhibits the recurrence and progression of bladder cancer by enhancing tumour‐specific immunity
authors: Zezhong Mou, Yiling Chen, Zheyu Zhang, Xinan Chen, Yun Hu, Lujia Zou, Chenyang Xu, Haowen Jiang
date: 2023
journal: Clinical and Translational Medicine
title: The novel hepatoprotective mechanisms of silibinin-phospholipid complex against d-GalN/LPS-induced acute liver injury
authors: Shan Tang, Xiaodan Zhang, Zhongping Duan, Manman Xu, Ming Kong, Sujun Zheng, Li Bai, Yu Chen
date: 2023
journal: INTERNATIONAL IMMUNOPHARMACOLOGY
title: JMJD6 in tumor-associated macrophage regulates macrophage polarization and cancer progression via STAT3/IL-10 axis
authors: Chen Siyuan, Wang Manni, Lu Tianqi, Liu Yu, Hong Weiqi, He Xuemei, Cheng Yuan, Liu Jian, Wei Yuquan, Wei Xiawei
date: 2023
journal: ONCOGENE
title: Water extracts of Tibetan medicine Wuweiganlu attenuates experimental arthritis via inducing macrophage polarization towards the M2 type
authors: Yuanyuan Wen, Shijie Zhang, Xinyu Meng, Chenyang Zhao, Bao Hou, Xuexue Zhu, Weiwei Cai, Yuetao Zhou, Liying Qiu, Haijian Sun
date: 2023
journal: JOURNAL OF ETHNOPHARMACOLOGY
title: Caffeoylquinic acids isolated from Lonicera japonica Thunb. as TAK1 inhibitors protects against LPS plus IFN-γ-stimulated inflammation by interacting with KEAP1-regulated NRF2 activation
authors: Lanlan Ge, Yuanyuan Jiang, Yangfang Li, Qiujie Xie, Yuyang Miao, Zhengzhi Wu, Xiaobin Zeng
date: 2023
journal: BIOMEDICINE & PHARMACOTHERAPY
title: KRT17 promotes T-lymphocyte infiltration through the YTHDF2-CXCL10 axis in colorectal cancer
authors: Liang Wenfeng, Liu Huashan, Zeng Ziwei, Liang Zhenxing, Xie Hao, Li Wenxin, Xiong Li, Liu Zhihang, Chen Mian, Jie Haiqing, Zheng Xiaobin, Huang Liang, Kang Liang
date: 2023
journal: Cancer Immunology Research
title: Tubuloside B, isolated from Cistanche tubulosa, a promising agent against M1 macrophage activation via synergistically targeting Mob1 and ERK1/2
authors: Lingyun Xiao, Jie Yao, Yuyang Miao, Baoru Ou, Jie Wang, Yongqi Huang, Boping Zhou, Lanlan Ge, Jun Tian, Xiaobin Zeng
date: 2022
journal: BIOMEDICINE & PHARMACOTHERAPY
MDSD
Reviews
Write Your Own Review